Profile
Klaus Godl is currently the Head of Research at Evotec (München) GmbH since 2009.
Previously, he worked as a Principal at GPC Biotech AG in 2006 and as a Scientist at Axxima Pharmaceuticals AG from 2001 to 2009.
Dr. Godl obtained his doctorate degree from the University of Regensburg in 1993.
Klaus Godl active positions
| Companies | Position | Start |
|---|---|---|
Evotec (München) GmbH
Evotec (München) GmbH Chemicals: Major DiversifiedProcess Industries Provides manufacturing and research support services for pharmaceutical and biotechnology companies | Chief Tech/Sci/R&D Officer | - |
Former positions of Klaus Godl
| Companies | Position | End |
|---|---|---|
Axxima Pharmaceuticals AG
Axxima Pharmaceuticals AG Miscellaneous Commercial ServicesCommercial Services Researches and develops drugs | Corporate Officer/Principal | 05/02/2009 |
GPC Biotech AG
GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes new anticancer drugs | Corporate Officer/Principal | 01/01/2006 |
Training of Klaus Godl
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
GPC Biotech AG
GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes new anticancer drugs | Commercial Services |
Axxima Pharmaceuticals AG
Axxima Pharmaceuticals AG Miscellaneous Commercial ServicesCommercial Services Researches and develops drugs | Commercial Services |
University of Regensburg
University of Regensburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evotec (München) GmbH
Evotec (München) GmbH Chemicals: Major DiversifiedProcess Industries Provides manufacturing and research support services for pharmaceutical and biotechnology companies | Process Industries |
- Stock Market
- Insiders
- Klaus Godl
















